Deutsche Bank’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Deutsche Bank's ELV Position: Q1 2026 in Review
Deutsche Bank increased its Elevance Health (ELV) stake by 3.8% in Q1 2026, buying an estimated $11M and bringing the position to 923,423 shares worth $270M. The position accounts for 0.09% of the portfolio, ranked #213.
Deutsche Bank first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $522M in Q4 2022. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Deutsche Bank held 923,423 shares of Elevance Health worth $270M as of Q1 2026.
- Deutsche Bank bought 33,587 Elevance Health shares in Q1 2026, an estimated $11M.
- Elevance Health made up 0.09% of Deutsche Bank's portfolio in Q1 2026, its #213 holding.
- Deutsche Bank first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Deutsche Bank's Elevance Health position peaked at $522M in Q4 2022.
- 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.